MARKET

FNA

FNA

Paragon 28 Inc
NYSE
9.82
+0.17
+1.76%
Opening 12:03 04/19 EDT
OPEN
9.93
PREV CLOSE
9.65
HIGH
9.93
LOW
9.75
VOLUME
75.17K
TURNOVER
0
52 WEEK HIGH
19.72
52 WEEK LOW
7.95
MARKET CAP
814.14M
P/E (TTM)
-16.8497
1D
5D
1M
3M
1Y
5Y
Many Still Looking Away From Paragon 28, Inc. (NYSE:FNA)
Paragon 28, Inc.'s price-to-sales ratio of 3.7x is middle-of-the-road for companies in the Medical Equipment industry in the U.S. Paragon 28 grew revenue by 19% last year and is expected to grow 18% in the next three years. The company's P/S ratio is closely matching its industry peers. But the company's revenue growth isn't enough to justify its high valuation.
Simply Wall St · 2d ago
Weekly Report: what happened at FNA last week (0408-0412)?
Weekly Report · 4d ago
Needham sees BSX, CNMD, RMD beating Street, despite medtech slow down
Needham sees BSX, CNMD, RMD and Surmodics beating Street, despite medtech slow down. Needham estimates medtech sales grew less than expected in Q1, but that Boston Scientific, CONMED and ResMed should still beat the Street. The investment firm says medtech market only grew by 5.3% in the first quarter of 2024.
Seeking Alpha · 4d ago
Weekly Report: what happened at FNA last week (0401-0405)?
Weekly Report · 04/08 09:24
Paragon 28 Price Target Maintained With a $18.00/Share by Stephens & Co.
Dow Jones · 04/05 13:24
Stephens & Co. Reiterates Overweight on Paragon 28, Maintains $18 Price Target
Benzinga · 04/05 13:15
Analysts Offer Insights on Healthcare Companies: Cardiol Therapeutics (CRDL), Paragon 28 (FNA) and Intra-Cellular Therapies (ITCI)
TipRanks · 04/05 11:00
Analysts Are Bullish on Top Healthcare Stocks: Paragon 28 (FNA), Caribou Biosciences (CRBU)
TipRanks · 04/05 09:00
More
About FNA
Paragon 28, Inc. is a medical device company. The Company develops, distributes, and sells medical devices in the foot and ankle segment of the orthopedic implant marketplace. Its products and product families include plates and plating systems, screws, staples, and nails to address all foot and ankle procedures, including fracture fixation, forefoot, or hallux valgus, which includes bunion and hammertoe, ankle, flatfoot, or progressive collapsing foot deformity (PCDF), Charcot foot and Ortho biologics. It provides a comprehensive portfolio of solutions that includes surgical implants and disposables, as well as surgical instrumentation. The Company’s suite of surgical solutions comprises 75 product systems, including approximately 9,200 SKUs, which comprises of approximately 6,800 implants, 1,400 instruments and 1,000 disposable and other SKUs. Its products are available in a variety of sizes and configurations to suit the individual patient’s anatomical and surgical requirements.

Webull offers Paragon 28 Inc stock information, including NYSE: FNA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, FNA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading FNA stock methods without spending real money on the virtual paper trading platform.